238 related articles for article (PubMed ID: 24569457)
1. Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation.
Dill MT; Makowska Z; Trincucci G; Gruber AJ; Vogt JE; Filipowicz M; Calabrese D; Krol I; Lau DT; Terracciano L; van Nimwegen E; Roth V; Heim MH
J Clin Invest; 2014 Apr; 124(4):1568-81. PubMed ID: 24569457
[TBL] [Abstract][Full Text] [Related]
2. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.
Sarasin-Filipowicz M; Wang X; Yan M; Duong FH; Poli V; Hilton DJ; Zhang DE; Heim MH
Mol Cell Biol; 2009 Sep; 29(17):4841-51. PubMed ID: 19564419
[TBL] [Abstract][Full Text] [Related]
3. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
Dill MT; Makowska Z; Duong FHT; Merkofer F; Filipowicz M; Baumert TF; Tornillo L; Terracciano L; Heim MH
Gastroenterology; 2012 Sep; 143(3):777-786.e6. PubMed ID: 22677194
[TBL] [Abstract][Full Text] [Related]
5. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
6. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
7. Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo.
Makowska Z; Duong FH; Trincucci G; Tough DF; Heim MH
Hepatology; 2011 Apr; 53(4):1154-63. PubMed ID: 21480323
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
11. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
[TBL] [Abstract][Full Text] [Related]
12. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
13. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
[TBL] [Abstract][Full Text] [Related]
14. The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.
El-Saadany S; Ziada DH; El Bassat H; Farrag W; El-Serogy H; Eid M; Abdallah M; Ghazy M; Salem HA
Can J Gastroenterol; 2013 Feb; 27(2):e13-7. PubMed ID: 23472246
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
16. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.
Younossi ZM; Birerdinc A; Estep M; Stepanova M; Afendy A; Baranova A
J Transl Med; 2012 Feb; 10():25. PubMed ID: 22313623
[TBL] [Abstract][Full Text] [Related]
17. Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
Reinharz V; Ishida Y; Tsuge M; Durso-Cain K; Chung TL; Tateno C; Perelson AS; Uprichard SL; Chayama K; Dahari H
J Virol; 2021 Jun; 95(14):e0049220. PubMed ID: 33910953
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.
Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M
Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.
Lee CM; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH; Yen YH
J Formos Med Assoc; 2016 Jun; 115(6):440-4. PubMed ID: 26786212
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
